BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2470735)

  • 1. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
    Wun TC; Palmier MO; Siegel NR; Smith CE
    J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
    Lindahl T; Wiman B
    Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catabolism of tissue-type plasminogen activator by the human hepatoma cell line Hep G2. Modulation by plasminogen activator inhibitor type 1.
    Morton PA; Owensby DA; Sobel BE; Schwartz AL
    J Biol Chem; 1989 May; 264(13):7228-35. PubMed ID: 2540181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
    Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
    J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.
    Wagner OF; Vetterlein M; Binder BR
    J Biol Chem; 1986 Nov; 261(31):14474-81. PubMed ID: 3490474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
    Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
    Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.
    Andreasen PA; Nielsen LS; Kristensen P; Grøndahl-Hansen J; Skriver L; Danø K
    J Biol Chem; 1986 Jun; 261(17):7644-51. PubMed ID: 3086313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of plasminogen activator inhibitor type-1 to extracellular matrix of Hep G2 cells. Evidence that the binding protein is vitronectin.
    Owensby DA; Morton PA; Wun TC; Schwartz AL
    J Biol Chem; 1991 Mar; 266(7):4334-40. PubMed ID: 1705551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
    Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
    J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma.
    Wiman B; Almquist A; Sigurdardottir O; Lindahl T
    FEBS Lett; 1988 Dec; 242(1):125-8. PubMed ID: 2462509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract.
    Radtke KP; Wenz KH; Heimburger N
    Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1119-27. PubMed ID: 1708670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.
    Sprengers ED; Princen HM; Kooistra T; van Hinsbergh VW
    J Lab Clin Med; 1985 Jun; 105(6):751-8. PubMed ID: 2987382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level.
    Wun TC; Capuano A
    Blood; 1987 May; 69(5):1354-62. PubMed ID: 3105619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H; Stephens RW; Nakagawa T; McNicol D
    J Biochem; 1988 Dec; 104(6):960-7. PubMed ID: 3149640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
    Sakata Y; Okada M; Noro A; Matsuda M
    J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of plasminogen activator inhibitor 1 biosynthesis by hyperthermia.
    Bergonzelli GE; Kruithof EK
    J Cell Physiol; 1991 Aug; 148(2):306-13. PubMed ID: 1652590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin.
    Salonen EM; Vaheri A; Pöllänen J; Stephens R; Andreasen P; Mayer M; Danø K; Gailit J; Ruoslahti E
    J Biol Chem; 1989 Apr; 264(11):6339-43. PubMed ID: 2467912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
    Hekman CM; Loskutoff DJ
    Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin.
    Seiffert D; Loskutoff DJ
    J Biol Chem; 1991 Feb; 266(5):2824-30. PubMed ID: 1704366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.